Bulk supplies for pivotal trials in the UK: We’re a specialist pharmaceutical supply company meeting global client requirements for clinical development. ClientPharma offers innovative sourcing and supply solutions from pre-clinical through to Phases I, II and III. Throughout the lifecycle of your drug development, it is our strategic approach that provides effective, tailored solutions that streamline the many complexities, avoiding supply chain disruptions and costly delays. See more details on clinical research reliable commercial drug sourcing.

Our worldwide reach provides unrivalled service and unmatched access. From provision of samples to bulk supplies for your pivotal programs, we have the skills, relationships and deep understanding to give you critical information, confidence and peace-of-mind. We’ve built robust and comprehensive networks to ensure we exceed every expectation, providing elegant supply solutions worldwide. Reducing complexity and maximizing value – that’s our mission.

From sample requests to global bulk supply procurement and distribution, we work as an extension of your team to guide you through the appropriate steps to mitigate risks. From start-to-finish, we utilize our extensive expertise and breadth of knowledge to navigate: Market Intelligence; Supply Chain Planning; Risk Management; Sourcing; Waste Management; Storage & Distribution; Documentation Management; Returns, Reconciliation & Destruction Services.

Our temperature-controlled capabilities include 2°- 8°C and 15°- 25°C facilities, as well as access to specialist transport to manage deliveries around the world according to product temperature requirements. Extensive capabilities: Our capabilities include stock receipt, import & export expertise, in-territory regulatory specialists, product reconciliation and destruction services. You can trust us: Our highly trained logistics team is dedicated to providing a robust clinical trial supply chain and trusted product integrity with regulatory compliant distribution through validated temperature-controlled logistics. We provide the peace-of-mind you need, offering you with dedicated clinical trial supply chain solutions to meet the explicit needs of your clinical programs. Find extra information at clientpharma.com.

Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”

When volatility of the market is coupled with the increasing complexity of the manufacturing process it creates a new drive for manufacturing solutions. Recently, pharmaceutical companies have begun to move away from conventional forms of manufacturing to use more flexible and modular models. These models are said to increase capacity, reduce costs and decrease development time in clinical trials. Flexibility in the manufacturing process also means that capacity for a drug can be scaled down to accommodate variability and volatility in the market. This can in turn reduce inaccurate estimates when supplying new medicines. Using this model, clients can then increase and decrease orders as and when they need to rather than bulk buying and ending up with surplus. In addition to these new approaches, disposable equipment has also become a major solution. Components such as hoses and bags are swapped over during the process, meaning that production never needs to stop. Although these approaches are often seen as more costly than traditional methods in the first instance, their benefits often out way their risks by creating a more flexible process.